Literature DB >> 3076819

New antibacterial drugs for the treatment of mycobacterial disease in man.

D A Mitchison, G A Ellard, J Grosset.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3076819     DOI: 10.1093/oxfordjournals.bmb.a072281

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


× No keyword cloud information.
  5 in total

1.  Rifapentine is active in vitro and in vivo against Toxoplasma gondii.

Authors:  F G Araujo; A A Khan; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

2.  Large-scale DNA fingerprinting of Mycobacterium tuberculosis strains as a tool for epidemiological studies of tuberculosis.

Authors:  D Chevrel-Dellagi; A Abderrahman; R Haltiti; H Koubaji; B Gicquel; K Dellagi
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

3.  Genetic characterization of Mycobacterium avium isolates recovered from humans and animals in Australia.

Authors:  M M Feizabadi; I D Robertson; D V Cousins; D Dawson; W Chew; G L Gilbert; D J Hampson
Journal:  Epidemiol Infect       Date:  1996-02       Impact factor: 2.451

4.  Diagnostic and therapeutic management of atypical mycobacterial infections in children.

Authors:  I Dhooge; C Dhooge; F De Baets; P Van Cauwenberge
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

5.  Characterization of epidemic and nonepidemic Neisseria meningitidis serogroup A strains from Sudan and Sweden.

Authors:  M A Salih; D Danielsson; A Bäckman; D A Caugant; M Achtman; P Olcén
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.